Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Target ID: TTDS00494

Target Information
NameBiliverdin reductase A    
Type of targetSuccessful target    
BVR A    
Biliverdin-IX alpha-reductase    
DiseasePrimary biliary cirrhosis
[ICD9: 571.6   ICD10: K74.3]
Drug(s)Ursodeoxycholic acidApprovedPrimary biliary cirrhosis[1][2]
BioChemical ClassOxidoreductases acting on the CH-CH group of donors    
EC NumberEC
UniProt IDP53004
PDB Structure2H63.    
FunctionReduces the gamma-methene bridge of the open tetrapyrrole, biliverdin ix alpha, to bilirubin with the concomitant oxidation of a nadh or nadph cofactor.    
ActivatorUrsodeoxycholic acid[1][2]
Cross References 3D Structure
Related Literature
On-Line Medical Dictionary
Ref 1Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):327-36. Epub 2008 Jul 23. To Reference
Ref 2Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007 Oct;46(4):1131-7. To Reference
Ref 3Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543